slowly slowly ……...
still not sure until they try first in human ?
granted they have a lot of success ... in everything but humans … not sure that makes it 50/50 ?
next year will be the real test ?
potentially it's worth many folds the current value as it always has …
getting expensive from the lab until either somebody is prepared to pay for it or it shows its worth ?
cash in hand is definitely a big plus
Not sure it translates to 14 Q's as the forward estimates though
Unless they plan on staying in the lab for 14Q's ?
Ann: March 2020 Quarterly Activities and Cash Flow Report, page-4
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $886.5M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 17.5¢ | $508.8K | 2.763M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 118941 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 183634 | 2 |
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |
Day chart unavailable